XML 62 R52.htm IDEA: XBRL DOCUMENT
v3.23.3

OTHER (INCOME)/EXPENSE, NET - Narrative (Details) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | 36 Months Ended | 38 Months Ended |  |
--- | --- | --- | --- | --- | --- | ---
Sep. 30, 2023 USD ($) | Mar. 31, 2022 USD ($) | Sep. 30, 2023 USD ($) | Sep. 30, 2026 USD ($) | Sep. 30, 2026 USD ($) payment | Aug. 31, 2023 shares | Jul. 31, 2023 lawsuit
Nimbus Therapuetics TYK2 Inhibitor |  |  |  |  |  |  |
Licensing Arrangements [Line Items] |  |  |  |  |  |  |
Proceeds from legal settlements |  | $ 40 | $ 400 |  |  |  |
AZ AB |  |  |  |  |  |  |
Licensing Arrangements [Line Items] |  |  |  |  |  |  |
Number of litigations | lawsuit |  |  |  |  |  |  | 2
Settlement amount | $ 384 |  |  |  |  |  |
AZ AB | Forecast |  |  |  |  |  |  |
Licensing Arrangements [Line Items] |  |  |  |  |  |  |
Settlement amount |  |  |  | $ 560 |  |  |
Number of payments | payment |  |  |  |  | 4 |  |
Proceeds from legal settlements |  |  |  |  | $ 418 |  |
BeiGene |  |  |  |  |  |  |
Licensing Arrangements [Line Items] |  |  |  |  |  |  |
Litigation settlement, number of shares transferred (in shares) | shares |  |  |  |  |  | 23.3 |
Litigation settlement expense | $ 322 |  |  |  |  |  |

X
- Definition Licensing Arrangements + References No definition available. + Details
Name: | bmy_LicensingArrangementsLineItems
Namespace Prefix: | bmy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Litigation Settlement, Number Of Payments + References No definition available. + Details
Name: | bmy_LitigationSettlementNumberOfPayments
Namespace Prefix: | bmy_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Litigation Settlement, Number Of Shares Transferred + References No definition available. + Details
Name: | bmy_LitigationSettlementNumberOfSharesTransferred
Namespace Prefix: | bmy_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Litigations, Number + References No definition available. + Details
Name: | bmy_LossContingencyLitigationsNumber
Namespace Prefix: | bmy_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount awarded from other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received for the settlement of litigation during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | bmy_LicensingAndOtherArrangementsAxis=bmy_NimbusTherapueticsTYK2InhibitorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bmy_AZABMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=bmy_BeiGeneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |